Rose Geoffrey Beran Insider Trading Activity
Rose Geoffrey Beran has been net-selling over the last 12 months with 0 purchases and 12 sales across 1 company.
LUNG is the most-traded position with 12 trades. The largest single transaction was a sale of LUNG for $4K on Mar 2, 2026.
Performance Scorecard
Forward stock performance after each transaction by Rose Geoffrey Beran. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -4.6% | 53% | 17 |
| 90 days | — | +8.5% | 53% | 17 |
| 120 days | — | +11.6% | 76% | 17 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersLUNG · Pulmonx Corp
🔒 Subscribe to see trade entries
Pro members see exactly when Rose Geoffrey Beran bought and sold LUNG.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Mar 2, 2026 | LUNG | Sell | 835 | $1.43 | $1K | −0.2% | CHIEF COMMERCIAL OFFICER | |
Mar 2, 2026 | LUNG | Sell | 2,125 | $1.43 | $3K | −0.6% | CHIEF COMMERCIAL OFFICER | |
Mar 2, 2026 | LUNG | Sell | 1,861 | $1.43 | $3K | −0.5% | CHIEF COMMERCIAL OFFICER | |
Mar 2, 2026 | LUNG | Sell | 2,911 | $1.43 | $4K | −0.8% | CHIEF COMMERCIAL OFFICER | |
Dec 1, 2025 | LUNG | Sell | 683 | $1.57 | $1K | −0.2% | CHIEF COMMERCIAL OFFICER | |
Dec 1, 2025 | LUNG | Sell | 1,738 | $1.57 | $3K | −0.5% | CHIEF COMMERCIAL OFFICER | |
Dec 1, 2025 | LUNG | Sell | 1,522 | $1.57 | $2K | −0.4% | CHIEF COMMERCIAL OFFICER | |
Dec 1, 2025 | LUNG | Sell | 2,379 | $1.57 | $4K | −0.6% | CHIEF COMMERCIAL OFFICER | |
Sep 2, 2025 | LUNG | Sell | 707 | $1.60 | $1K | −0.2% | CHIEF COMMERCIAL OFFICER | |
Sep 2, 2025 | LUNG | Sell | 1,799 | $1.60 | $3K | −0.5% | CHIEF COMMERCIAL OFFICER | |
Sep 2, 2025 | LUNG | Sell | 1,575 | $1.60 | $3K | −0.4% | CHIEF COMMERCIAL OFFICER | |
Sep 2, 2025 | LUNG | Sell | 2,462 | $1.60 | $4K | −0.6% | CHIEF COMMERCIAL OFFICER | |
Jun 2, 2025 | LUNG | Sell | 401 | $3.14 | $1K | −0.1% | CHIEF COMMERCIAL OFFICER | |
Jun 2, 2025 | LUNG | Sell | 708 | $3.13 | $2K | −0.2% | CHIEF COMMERCIAL OFFICER | |
Jun 2, 2025 | LUNG | Sell | 1,799 | $3.13 | $6K | −0.5% | CHIEF COMMERCIAL OFFICER | |
Jun 2, 2025 | LUNG | Sell | 1,576 | $3.13 | $5K | −0.4% | CHIEF COMMERCIAL OFFICER | |
Jun 2, 2025 | LUNG | Sell | 2,463 | $3.13 | $8K | −0.6% | CHIEF COMMERCIAL OFFICER |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| LUNG | Pulmonx Corp | 17 | $53K |
Other insiders at Pulmonx Corp
5 other tracked filers at LUNG.